[go: up one dir, main page]

KR960003724A - 간질환 치료용 약제조성물 - Google Patents

간질환 치료용 약제조성물 Download PDF

Info

Publication number
KR960003724A
KR960003724A KR1019940017855A KR19940017855A KR960003724A KR 960003724 A KR960003724 A KR 960003724A KR 1019940017855 A KR1019940017855 A KR 1019940017855A KR 19940017855 A KR19940017855 A KR 19940017855A KR 960003724 A KR960003724 A KR 960003724A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
formula
compound
weight
parts
Prior art date
Application number
KR1019940017855A
Other languages
English (en)
Other versions
KR0142809B1 (ko
Inventor
선종건
Original Assignee
선종건
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 선종건 filed Critical 선종건
Priority to KR1019940017855A priority Critical patent/KR0142809B1/ko
Publication of KR960003724A publication Critical patent/KR960003724A/ko
Application granted granted Critical
Publication of KR0142809B1 publication Critical patent/KR0142809B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 간질환 치료제로서 유용한 다음 구조식(1)의 비페닐 디메칠 디카복시레이트(DDB)와 다음 구조식(2)의 우르소데옥시콜린산(UDCA)을 함유한 약제조성물에 관한 것이다.

Description

간질환 치료용 약제조성용
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 다음 구조식(1)로 표시되는 비페닐디메칠 디카복시레이트(DDB)와 다음 구조식(2)로 표시되는 우르소데옥시콜린산(UDCA) 및 약제학적으로 허용되는 부형제로 이루어진 것을 특징으로 하는 약제조성물.
  2. 제1항에 있어서, 상기 구조식(1) 화합물은 폴리소르베이트 80과 폴리에칠렌글리콜 6000를 사용하여 통상의 용융－용매법으로 처리한 것임을 특징으로 하는 약제조성물.
  3. 제1항에 있어서, 상기 구조식(1) 화합물과 구조식(2) 화합물의 유효량은 각각 7∼30 중량부와 30∼100중량부로 혼합된 것임을 특징으로 하는 약제조성물.
  4. 제1항에 있어서, 상기 구조식(1) 화합물의 유효량이 25중량부이고, 구조식(2) 화합물의 유효량이 50중량부임을 특징으로 하는 약제조성물.
  5. 제1항에 있어서, 상기 구조식(2) 화합물의 유효량이 12.5 중량부이고, 구조식(2) 화합물의 유효량이 50중량임을 특징으로 하는 약제 조성물.
KR1019940017855A 1994-07-23 1994-07-23 간질환 치료용 약제조성물 KR0142809B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940017855A KR0142809B1 (ko) 1994-07-23 1994-07-23 간질환 치료용 약제조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940017855A KR0142809B1 (ko) 1994-07-23 1994-07-23 간질환 치료용 약제조성물

Publications (2)

Publication Number Publication Date
KR960003724A true KR960003724A (ko) 1996-02-23
KR0142809B1 KR0142809B1 (ko) 1998-07-15

Family

ID=19388643

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940017855A KR0142809B1 (ko) 1994-07-23 1994-07-23 간질환 치료용 약제조성물

Country Status (1)

Country Link
KR (1) KR0142809B1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100626414B1 (ko) * 2003-08-27 2006-09-20 선종건 간염 치료용 약제조성물

Also Published As

Publication number Publication date
KR0142809B1 (ko) 1998-07-15

Similar Documents

Publication Publication Date Title
KR950014073A (ko) 이소퀴놀린
ES8705393A1 (es) Un procedimiento para preparar un derivado de pirazol (como divisional de la solicitud de patente de invencion n 543.046, presentada el 10.5.85)
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
RU95113862A (ru) Производные пирролопиримидинов, фармацевтическая композиция, промежуточные соединения
KR890011837A (ko) 디데하이드로 비타민 d₃유도체
BR9401183A (pt) Composto e formulação farmacêutica
KR940002210A (ko) 24-시클로프로판 비타민 d 유도체
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
EA199800013A1 (ru) Способы минимизации остеопороза
MX9303139A (es) Procedimiento para la preparacion de derivados esteroides 11-ceto.
RU2218334C2 (ru) Замещенные 1,2,3,4,5,6-гексагидро-2,6-метано-3-бензазоцин-10-олы и фармацевтическая композиция на их основе
ATE107167T1 (de) Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten.
KR900009606A (ko) 불소-함유 2-니트로 이미다졸 유도체 및 그를 함유하는 방사선 증감제
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
ATE17727T1 (de) Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
KR960003724A (ko) 간질환 치료용 약제조성물
FI834800A0 (fi) Foerfarande foer framstaellning av dialkylaminoalkoxibensylalkohol-derivat
KR970705999A (ko) 타목시펜 및 타목시펜 유사체의 자궁향성 효과를 최소화시키는 방법 (a method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs)
CA2231025A1 (fr) Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69116404T2 (de) Tenidap als Hemmstoff der Elastinfreisetzung durch Neutrophile
ES2084348T3 (es) N-((4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il)carbonil)aminoacidos utiles en la terapia de afecciones osteoarticulares.
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
KR910019974A (ko) 치환된 인돌
JP3200723B2 (ja) 育毛剤

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19940723

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19940723

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19970908

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19980105

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19980403

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19980403

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20010404

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20020403

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20030325

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20040324

Start annual number: 7

End annual number: 7

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20040826

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 19980403

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20040826

Decision date: 20041021

Appeal identifier: 2004100001847

J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20041021

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2004100001847

Request date: 20040826

Appeal kind category: Invalidation

Decision date: 20041021

PR1001 Payment of annual fee

Payment date: 20050308

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20060404

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20070404

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20080404

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20090406

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20100423

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20110330

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20120403

Start annual number: 15

End annual number: 15

FPAY Annual fee payment

Payment date: 20130403

Year of fee payment: 16

PR1001 Payment of annual fee

Payment date: 20130403

Start annual number: 16

End annual number: 16

FPAY Annual fee payment

Payment date: 20140521

Year of fee payment: 17

PR1001 Payment of annual fee

Payment date: 20140521

Start annual number: 17

End annual number: 17

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20150123

Termination category: Expiration of duration